Home » Heroin Addiction and The British System
Product Image

Heroin Addiction and The British System

€42.99
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
ACMD
AIDS
Amphetamine Sulphate
Barbiturate Users
Brain Committee
British Drug Policy
British System
Category=JBFN2
Central Funding Initiative
clinical addiction services
Current Heroin Users
Drug Education
Drug Field
Drug Misusers
Drug Policy
Drug Services
Drug Users
eq_bestseller
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_society-politics
Harm Reduction
HCV Epidemic
Heroin Epidemic
Heroin Users
Injecting Drug Misusers
Injecting Drug Users
needle exchange programmes
opioid maintenance therapy
Pe Rc
public health interventions
qualitative drug research
Rolleston Committee
Rolleston Report
substance misuse policy
UK drug treatment policy evolution
Young Man

Product details

  • ISBN 9780415298155
  • Weight: 362g
  • Dimensions: 156 x 234mm
  • Publication Date: 23 Dec 2004
  • Publisher: Taylor & Francis Ltd
  • Publication City/Country: GB
  • Product Form: Paperback
Secure checkout Fast Shipping Easy returns
Description

The British system of dealing with drug addiction is notable for its flexibility and its capacity to adapt to changing circumstances. Because of this it has attracted considerable international interest, although it is rarely fully understood or accurately represented.

Presenting a comprehensive account of the development of policies and treatments, Heroin Addiction brings together the perspectives of policy makers, practitioners and social commentators. The book contributes to a proper understanding of how policy and practice has evolved so that lessons for future policy and practice may be identified.
Volume II of Heroin Addiction charts the development and use of treatment and policy responses in the UK, highlighting the limitations of these approaches as well as their achievements. It is a unique source of reference for students, researchers, healthcare professionals and drug agencies both in the UK and overseas.